U.S., July 31 -- ClinicalTrials.gov registry received information related to the study (NCT07735520) titled 'Feasibility and Acceptability of OLP-EXP in Chronic Pain' on July 24.

Brief Summary: The primary objective is to determine the feasibility of delivering OLP-EXP, EXP only, and OLP only over 6 weeks to adults with chronic TMD. The trial will be considered feasible for progression planning when the 6-week retention rate is at least 80% in each arm and average OLP pill adherence is at least 80% of prescribed days in each OLP arm.

Primary hypothesis: Each intervention arm will meet the prespecified 6-week retention benchmark, and each OLP arm will meet the prespecified pill-adherence benchmark.

The secondary objectives are:

1. To eva...